Randomized Dose-Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse of Plasmodium vivax Malaria in Thailand

DS Walsh, S Looareesuwan… - The Journal of …, 1999 - academic.oup.com
WR 238605 is an 8-aminoquinoline developed for the radical cure of Plasmodium vivax.
Forty-four P. vivax-infected patients were randomly assigned to 1 of 4 treatment regimens: 3 …
被引用次数：137 相关文章
[PDF] academia.edu

[PDF][PDF] Randomized Dose-Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse of Plasmodium vivax Malaria in …

DS Walsh, S Looareesuwan, P Wilairatana… - The Journal of …, 1999 - academia.edu
WR 238605 is an 8-aminoquinoline developed for the radical cure of Plasmodium vivax.
Forty-four P. vivax–infected patients were randomly assigned to 1 of 4 treatment regimens: 3 …

Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand

DS Walsh, S Looareesuwan… - Journal of …, 1999 - mahidol.elsevierpure.com
WR 238605 is an 8-aminoquinoline developed for the radical cure of Plasmodium vivax.
Forty-four P. vivax-infected patients were randomly assigned to 1 of 4 treatment regimens: 3 …

Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.

DS Walsh, S Looareesuwan, P Wilairatana… - 1999 - cabidigitallibrary.org
WR 238605, or tafenoquine, is an 8-aminoquinoline, a synthetic primaquine analogue,
developed for the radical cure of Plasmodium vivax. Between August 1996 and June 1997 …

Randomized Dose-Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse of Plasmodium vivax Malaria in Thailand

DS Walsh, S Looareesuwan, P Wilairatana… - The Journal of Infectious …, 1999 - JSTOR
WR 238605 is an 8-aminoquinoline developed for the radical cure of Plasmodium vivax.
Forty-four R vivajc-infected patients were randomly assigned to 1 of 4 treatment regimens: 3 …

Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand.

DS Walsh, S Looareesuwan, P Wilairatana… - The Journal of …, 1999 - europepmc.org
WR 238605 is an 8-aminoquinoline developed for the radical cure of Plasmodium vivax.
Forty-four P. vivax-infected patients were randomly assigned to 1 of 4 treatment regimens: 3 …

[引用][C] Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand

DS WALSH, S LOOAREESUWAN… - The Journal of …, 1999 - pascal-francis.inist.fr
Author WALSH, D. S 1; LOOAREESUWAN, S 2; SCHUSTER, B. G 4; HORTON, J 5;
BRAITMAN, D. J 6; BRUECKNER, R. P 4; WILAIRATANA, P 2; HEPPNER, D. G 1; TANG, D …

Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand

DS Walsh, S Looareesuwan… - The Journal of …, 1999 - pubmed.ncbi.nlm.nih.gov
WR 238605 is an 8-aminoquinoline developed for the radical cure of Plasmodium vivax.
Forty-four P. vivax-infected patients were randomly assigned to 1 of 4 treatment regimens: 3 …

Randomized Dose-Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the Prevention of Relapse of Plasmodium vivax Malaria in Thailand.

DS Walsh, S Looareesuwan… - Journal of Infectious …, 1999 - search.ebscohost.com
Randomized Dose-Ranging Study of the Safety and Efficacy of WR 238605 (Tafenoquine) in the
Prevention of Relapse of Plasmodium v Page 1 1282 Randomized Dose-Ranging Study of the …

[引用][C] Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand

DS WALSH, S LOOAREESUWAN… - The Journal of …, 1999 - Oxford University Press